Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome

Lipid and pleiotropic effects of atorvastatin in patients with acute coronary syndrome

Aim. To study the effects of an HMG-CoA reductase inhibitor atorvastatin in patients with acute coronary syndrome (ACS).Material and methods. The study included 116 ACS patients, divided into two comparable groups. Total follow-up time was 180±7 days.Results. In 6 months of the follow-up, the patien...

Full description

Bibliographic Details
Main Authors:	A. A. Yalymov, G G Shekhyan, A. A. Bylyeva, V. S. Zadionchenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	hmg-coa reductase inhibitor atorvastatin acute coronary syndrome microcirculation central hemodynamics endothelial dysfunction reology
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1609

Similar Items

The role of atorvastatin in suppressing tumor growth of uterine fibroids
by: Zhaojun Shen, et al.
Published: (2018-03-01)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
by: Gene C. Ness, et al.
Published: (1998-01-01)

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells
by: Koh Kitagawa, et al.
Published: (2020-10-01)

Studi Docking Molekuler Catechin Gallate, Epicatechin Gallate, Gallocatechin Gallate, dan Epigallocatechin Gallate sebagai Obat Dislipidemia
by: Ani Isnawati, et al.
Published: (2015-05-01)

Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
by: Lisa J. Wilcox, et al.
Published: (1999-06-01)

Evaluation of Atorvastatin Safety on Liver Function Tests, a Prospective Study
by: Ramin Talaie, et al.
Published: (2015-07-01)

Antihyperlipidemic studies of newly synthesized phenolic derivatives: in silico and in vivo approaches
by: Aqeel MT, et al.
Published: (2018-08-01)

Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test
by: Dick C. Chan, et al.
Published: (2002-05-01)

Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease
by: Yuanyuan Xu, et al.
Published: (2017-04-01)

Control of HMG-CoA reductase activity and sterol synthesis in the lactating mammary gland
by: Smith, R. A. W.
Published: (1987)

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
by: Choi Y, et al.
Published: (2018-07-01)

Effect of Diallyl Disulphide on Diabetes Induced Dyslipidemia in Male Albino Rats
by: Naveen Kumar Sambu, et al.
Published: (2015-04-01)

ENDOTHELIUM AND CARDIOPROTECTIVE EFFECTS OF HMG-CO-A-REDUCTASE IN COMBINATION WITH L-ARGININE IN ENDOTHELIAL DYSFUNCTION MODELING
by: Tatiana Denisyuk, et al.
Published: (2016-03-01)

7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts
by: Megumi Honda, et al.
Published: (1998-03-01)

Estatinas hipolipêmicas e novas tendências terapêuticas Hypolipemic statins and new therapeutcal trends
by: Vanessa Leiria Campo, et al.
Published: (2007-04-01)

Single dose testosterone increases total cholesterol levels and induces the expression of HMG CoA Reductase
by: Gårevik Nina, et al.
Published: (2012-03-01)

Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography
by: I P Williamson, et al.
Published: (1981-01-01)

The quantitative assay of 3-hydroxy-3-methylglutaryl coenzyme A reductase: comparison of a thin-layer chromatographic assay with a rapid chloroform extraction assay
by: M E Ackerman, et al.
Published: (1977-05-01)

PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin
by: Maria Giovanna Lupo, et al.
Published: (2021-04-01)

Inhibition of HMG CoA Reductase and Lipid Peroxidation in The Rats Liver by Selected Zingiberaceae
by: Patonah Hasimun, et al.
Published: (2018-11-01)

The effects of different doses of atorvastatin on serum lipid profile, glycemic control, and liver enzymes in patients with ischemic cerebrovascular accident
by: Roxana Sadeghi, et al.
Published: (2014-11-01)

Efficacy of Generic Atorvastatin in a Real-World Setting
by: Manasirisuk P, et al.
Published: (2021-03-01)

The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells
by: Layton Harris Smith, et al.
Published: (2005-05-01)

3-Hydroxy-3-methylglutaryl coenzyme A reductase in isolated villous and crypt cells of the rat ileum
by: J L Merchant, et al.
Published: (1977-11-01)

[18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action
by: Gonçalo S. Clemente, et al.
Published: (2020-04-01)

Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
by: Nijole Bernaitis, et al.
Published: (2018-05-01)

Studies on the HMG-CoA reductase gene expression in the human parasite Schistosoma mansoni
by: Rajkovic, Aleksandar
Published: (1991)

Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis
by: Ian R. Harris, et al.
Published: (1998-02-01)

Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen levels
by: A. V. Susekov, et al.
Published: (2006-12-01)

Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
by: Heshun Chen, et al.
Published: (1993-12-01)

Liver biochemistry abnormalities in a quaternary care lipid clinic database
by: Holly A.R. Wiesinger, et al.
Published: (2008-01-01)

A QM/MM Evaluation of the Missing Step in the Reduction Mechanism of HMG-CoA by Human HMG-CoA Reductase
by: Paula Mihaljević-Jurič, et al.
Published: (2021-06-01)

Gene expression of sterol regulatory element-binding proteins in hamster small intestine
by: F. Jeffrey Field, et al.
Published: (2001-01-01)

Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome
by: N V Blinova, et al.
Published: (2015-03-01)

Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?
by: Afshan Siddiq, et al.
Published: (2011-01-01)

Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01)

Pre and post-stroke use of statins improves stroke outcome
by: Majaz Moonis, et al.
Published: (2014-01-01)

Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
by: Paškevičiūtė M, et al.
Published: (2017-11-01)

Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study
by: Abraham Simatupang, et al.
Published: (2018-10-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)